No tradeable signal. This filing is purely administrative with no impact on valuation, pipeline, or financial outlook. Monitor upcoming clinical catalysts or earnings for material events.
GMAB drugs
GMAB drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 16 $24.74entry
- T+1 · 5mo ago +2.63%α +3.88% · $25.39
- T+5 · 5mo ago +4.85%α +7.08% · $25.94
- T+20 · 4mo ago +16.13%α +15.93% · $28.73
- T+60 · 2mo ago +30.27%α +29.28% · $32.23
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Genmab filed a 6-K reporting a de minimis capital increase of 185 shares (DKK 0.2 million proceeds) from employee warrant exercises, representing less than 0.001% of share capital. This is a routine administrative event with no material impact on the company's financials or operations.
Key Facts
- Capital increase of 185 shares at DKK 1,334.50 per share
- Proceeds of approximately DKK 0.2 million
- Represents less than 0.001% of Genmab's share capital
- Total share capital after increase: DKK 62,353,252 (62,353,252 shares)
Financial Impact
De minimis, DKK 0.2 million proceeds, negligible dilution
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001434265-26-000094 |
| Document: gmab_20260616x6k.htm | 0001434265-26-000094 |
| Document: 0001434265-26-000094-index-headers.html | 0001434265-26-000094 |
| Document: 0001434265-26-000094-index.html | 0001434265-26-000094 |
| Document: 0001434265-26-000094.txt | 0001434265-26-000094 |
Track record
31 reports on GMAB
3 of 5 bullish or bearish reports moved the stock their way by T+20. Best: +91.28% at T+60 after the Aug 6, 2026 report. 5 of 7 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $52.12 Now $51.57 −1.06% settles Dec 15
- Nov 12, 20264d ago 6-K Neutral 2/10 Entry $51.74 Now $51.57 −0.33% settles Dec 11
- Nov 12, 20264d ago 6-K Neutral 2/10 Entry $51.74 Now $51.57 −0.33% settles Dec 11
- Nov 12, 20264d ago 6-K Neutral 2/10 Entry $51.74 Now $51.57 −0.33% settles Dec 11
- Nov 12, 20264d ago 6-K Neutral 2/10 Entry $51.74 Now $51.57 −0.33% settles Dec 11
- Nov 10, 20266d ago 6-K Neutral 2/10 Entry $53.87 Now $51.57 −4.27% settles Dec 10
- Nov 10, 20266d ago 144 Neutral 2/10 Entry $54.07 Now $51.57 −4.62% settles Dec 9
- Nov 5, 202611d ago 6-K Neutral 5/10 Entry $52.74 Now $51.57 −2.22% settles Dec 4
- Nov 4, 202612d ago Institutional Cluster Neutral 2/10 Entry $52.74 Now $51.57 −2.22% settles Dec 4
- Oct 28, 202619d ago 6-K Bullish 6/10 Entry $57.29 Now $51.57 −9.98% settles Nov 25
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers